Polymorphism in the Angiotensin II Type 1 Receptor (AGTR1) is Associated With Age at Diagnosis in Pulmonary Arterial Hypertension

Journal of Heart and Lung Transplantation

Volumn 28, Issue 4, 2009, Pages 373-379

  Chung, Wendy K ^a   Deng, Liyong ^a   Carroll, J Sheila ^b   Mallory, Nicole ^a   Diamond, Beverly ^c   Rosenzweig, Erika Berman ^a   Barst, Robyn J ^a   Morse, Jane H ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CARDIAC CHYMASE A; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ACE GENE; ADULT; AGT GENE; AGTR1 GENE; ALLELE; ARTICLE; CMA1 GENE; CONNECTIVE TISSUE DISEASE; CYP11B2 GENE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; IDIOPATHIC DISEASE; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALDOSTERONE SYNTHASE; CHYMASES; CONNECTIVE TISSUE DISEASES; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; YOUNG ADULT;

EID: 62949107114     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.01.016     Document Type: Article

References (43)

1. Widlitz A., and Barst R.J. Pulmonary arterial hypertension in children. Eur Respir J 21 (2003) 155-176
2. Wagenvoort C.A., and Wagenvoort N. Primary pulmonary hypertension. A pathological study of the lung vessels in 156 clinically diagnosed cases. Circulation 42 (1970) 1163-1184
3. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 (2004) 5S-12S
4. Runo J.R., and Loyd J.E. Primary pulmonary hypertension. Lancet 361 (2003) 1533-1544
5. Rich S. The current treatment of pulmonary arterial hypertension: time to redefine success. [see comment]. Chest 130 (2006) 1198-1202
6. Deng Z., Morse J.H., Slager S.L., et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67 (2000) 737-744
7. Lane K.B., Machado R.D., Pauciulo M.W., et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26 (2000) 81-84
8. Trembath R.C., Thomson J.R., Machado R.D., et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345 (2001) 325-334
9. Gallione C.J., Klaus D.J., Yeh E.Y., et al. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat 11 (1998) 286-294
10. Roberts K.E., McElroy J.J., Wong W.P., et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 24 (2004) 371-374
11. Humbert M., Deng Z., Simonneau G., et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 20 (2002) 518-523
12. Morse J., Barst R., Horn E., Cuervo N., Deng Z., and Knowles J. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 29 (2002) 2379-2381
13. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 (1987) 216-223
14. Machado R.D., Pauciulo M.W., Thomson J.R., et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68 (2001) 92-102
15. Haworth S.G. Pathobiology of pulmonary hypertension in infants and children. Prog Pediatr Cardiol 12 (2001) 249-269
16. Christman B.W., McPherson C.D., Newman J.H., et al. An imbalance between the excretion of thromboxane and protacyclin metabolites in pulmonary hypertension. N Engl J Med 327 (1991) 6
17. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114 (1998) 208S-212S
18. Yoshibayashi M., Nishioka K., Nakao K., et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84 (1991) 2280-2285
19. Abraham W.T., Raynolds M.V., Badesch D.B., et al. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics. J Renin Angiotensin Aldosterone Syst 4 (2003) 27-30
20. Tanabe N., Amano S., Tatsumi K., et al. Angiotensin-converting enzyme gene polymorphisms and prognosis in chronic thromboembolic pulmonary hypertension. Circ J 70 (2006) 1174-1179
21. Solari V., and Puri P. Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension. J Pediatr Surg 39 (2004) 302-306 discussion 302-6
22. Orte C., Polak J.M., Haworth S.G., Yacoub M.H., and Morrell N.W. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 192 (2000) 379-384
23. Okada K., Bernstein M.L., Zhang W., Schuster D.P., and Botney M.D. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am J Respir Crit Care Med 158 (1998) 939-950
24. Sitbon O., Humbert M., Jagot J.L., et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 12 (1998) 265-270
25. Casiglia E., Tikhonoff V., Mazza A., et al. C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens 23 (2005) 1991-1996
26. Kurland L., Melhus H., Karlsson J., et al. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Am J Hypertens 15 (2002) 389-393
27. Ortlepp J.R., Vosberg H.P., Reith S., et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 87 (2002) 270-275
28. Padmanabhan N., Padmanabhan S., and Connell J.M. Genetic basis of cardiovascular disease-the renin-angiotensin-aldosterone system as a paradigm. J Renin Angiotensin Aldosterone Syst 1 (2000) 316-324
29. Pagliaro P., and Penna C. Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther 19 (2005) 77-87
30. Schmidt S., Beige J., Walla-Friedel M., Michel M.C., Sharma A.M., and Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 15 (1997) 1385-1388
31. Staessen J.A., Wang J.G., Brand E., et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19 (2001) 1349-1358
32. Dzida G., Sobstyl J., Puzniak A., Golon P., Mosiewicz J., and Hanzlik J. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in a Polish population. Med Sci Monit 7 (2001) 1236-1241
33. Kainulainen K., Perola M., Terwilliger J., et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33 (1999) 844-849
34. Liyou N., Davis D., James K., et al. The A1166C mutation in the angiotensin II type I receptor and hypertension in the elderly. Clin Exp Pharmacol Physiol 26 (1999) 525-526
35. Sookoian S., Castano G., Garcia S.I., Viudez P., Gonzalez C., and Pirola C.J. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension. Am J Gastroenterol 100 (2005) 636-642
36. Amant C., Hamon M., Bauters C., et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 29 (1997) 486-490
37. van Geel P.P., Pinto Y.M., Voors A.A., et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35 (2000) 717-721
38. Thekkumkara T.J., and Linas S.L. Evidence for involvement of 3′-untranslated region in determining angiotensin II receptor coupling specificity to G-protein. Biochem J 370 (2003) 631-639
39. Dragun D., Muller D.N., Brasen J.H., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352 (2005) 558-569
40. Ruiz-Ortega M., Lorenzo O., Ruperez M., et al. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38 (2001) 1382-1387
41. van Kleef E.M., Fingerle J., and Daemen M.J. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated. Arterioscler Thromb Vasc Biol 16 (1996) 857-863
42. Yamani M.H., Cook D.J., Rodriguez E.R., et al. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. J Heart Lung Transplant 25 (2006) 1283-1289
43. Benetos A., Cambien F., Gautier S., et al. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 28 (1996) 1081-1084